Endocrine-related Cancer
Overview
Endocrine-related Cancer is a peer-reviewed journal that focuses on the study of cancers originating from endocrine glands or hormone-producing cells. It covers a wide range of topics including molecular biology, genetics, epidemiology, diagnosis, and treatment of endocrine-related cancers. The journal aims to provide valuable insights into the mechanisms underlying these cancers and to promote advancements in their management and prevention.
Details
Details
Abbr.
Endocr Relat Cancer
Start
1994
End
Continuing
Frequency
Quarterly
p-ISSN
1351-0088
e-ISSN
1479-6821
Country
United Kingdom
Language
English
Specialties
Oncology
Endocrinology
Endocrinology
Metrics
Metrics
h-index / Ranks: 1490
146
SJR / Ranks: 2373
1331
CiteScore / Ranks: 1426
10.00
JIF / Ranks: 2352
3.9
Recent Articles
1.
Park M, Park S, Lee B, Jang J, Kim W, Kim S, et al.
Endocr Relat Cancer
. 2025 Mar;
PMID: 40063012
Recent advances in genetic testing have challenged the traditional genotype-phenotype correlation in pheochromocytomas and paragangliomas (PPGL). We aimed to characterize the genotype-phenotype correlations in PPGL in a large Korean cohort...
2.
Silva A, Barry S, Lopes-Pinto M, Joaquim R, Miranda C, Reis F, et al.
Endocr Relat Cancer
. 2025 Mar;
PMID: 40063010
The crosstalk between tumour cells and microenvironment components in pituitary neuroendocrine tumours (PitNETs), including chemokines, may impact tumour behaviour and clinical outcomes. CCL2 was previously identified as a key chemokine...
3.
Quinn M, Kemkem Y, White G, Touska P, Christodoulou D, Jacques A, et al.
Endocr Relat Cancer
. 2025 Mar;
PMID: 40063004
Paragangliomas (PGLs) are neuroendocrine tumours (NETs) that arise from neural crest derived cells. Up to 40% of cases occur due to the presence of a pathogenic germline variant (PGV) in...
4.
Li Z, Song L, Yang Y, Zhao Y, Ma S
Endocr Relat Cancer
. 2025 Mar;
PMID: 40063000
Anaplastic thyroid cancer represents the most aggressive form of thyroid cancer and harbors BRAF mutations in over 40% of cases. Vemurafenib (PLX4032), a BRAF kinase inhibitor, shows promise in BRAFV600E-positive...
5.
Duskin-Bitan H, Perez A, Netzer D, Cohen A, Comaneshter D, Beckenstein T, et al.
Endocr Relat Cancer
. 2025 Mar;
PMID: 40062775
The association between acromegaly and cancer had been assessed mainly in population studies with inconsistent results. The objective of this study was to investigate the risk of cancer in a...
6.
Ostarijas E, Onyema M, Zair Z, Taylor D, Lajeunesse-Trempe F, Reynolds S, et al.
Endocr Relat Cancer
. 2025 Feb;
32(4).
PMID: 39985422
Brown adipose tissue (BAT) activity, identifiable through fluorodeoxyglucose positron emission tomography (FDG-PET), has gained interest due to its potential link with metabolic disorders and tumour pathophysiology. This study aims to...
7.
Saltiki K, Karapanou O, Kantreva K, Michalaki M, Koutsoukos K, Paschou S, et al.
Endocr Relat Cancer
. 2025 Feb;
32(4).
PMID: 39970869
A cohort of radioiodine-refractory differentiated thyroid cancer patients (RAI-R DTC) in a tertiary center underwent therapeutic interventions according to disease progression rate and metastasis location. We evaluated the independent impact...
8.
Venegas J, Onur O, Kang S, Hitomi M, Eng C
Endocr Relat Cancer
. 2025 Feb;
32(4).
PMID: 39970536
Germline mutations in the tumor suppressor phosphatase and tensin homolog (PTEN) cause PTEN hamartoma tumor syndrome (PHTS). PHTS is characterized by an elevated lifetime risk of differentiated thyroid cancer (DTC),...
9.
Califano I, Randolph G, Randolph G, Pitoia F
Endocr Relat Cancer
. 2025 Feb;
32(4).
PMID: 39963888
Neoadjuvant therapy has an emerging role in the management of locally advanced thyroid cancer. Recent developments in systemic therapies, particularly with the introduction of multikinase inhibitors and selective inhibitors, have...
10.
Chandra S, Halfdanarson T, Carlson E, Rabe K, Mahipal A, Majumder S, et al.
Endocr Relat Cancer
. 2025 Feb;
32(4).
PMID: 39932006
Pancreatic neuroendocrine neoplasm (panNEN) is a rare malignancy and the second most common type of pancreatic cancer after pancreatic ductal adenocarcinoma (PDAC), but its etiology is poorly understood. We investigated...